These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preventing renal disease progression: is it the drug or the blood pressure reduction, or both? Weir MR Curr Hypertens Rep; 2000 Dec; 2(6):497-9. PubMed ID: 11062593 [No Abstract] [Full Text] [Related]
6. Role of combination therapy with ACE inhibitors and calcium channel blockers in renal protection. Locatelli F; Del Vecchio L; Andrulli S; Colzani S Kidney Int Suppl; 2002 Dec; (82):S53-60. PubMed ID: 12410856 [TBL] [Abstract][Full Text] [Related]
7. Antihypertensive drugs and renal protection. Fukuda M; Usami T; Yoshida A; Kimura G JAMA; 2003 Mar; 289(9):1102-3; author reply 1103. PubMed ID: 12622571 [No Abstract] [Full Text] [Related]
9. Guiding lights for antihypertensive treatment in patients with nondiabetic chronic renal disease: proteinuria and blood pressure levels? Mulrow CD; Townsend RR Ann Intern Med; 2003 Aug; 139(4):296-8. PubMed ID: 12965986 [No Abstract] [Full Text] [Related]
10. Renoprotective effects of antihypertensive drugs. Preston RA Am J Hypertens; 1999 Jan; 12(1 Pt 2):19S-32S. PubMed ID: 10077416 [TBL] [Abstract][Full Text] [Related]
11. [Nephro-protection: role of arterial pressure in progression of renal pathology. Does a nephro-protective effect depend on the choice of antihypertensive drug?]. Shestakova MV Ter Arkh; 2001; 73(6):64-6. PubMed ID: 11521527 [No Abstract] [Full Text] [Related]
12. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091 [TBL] [Abstract][Full Text] [Related]
13. [Do angiotensin converting enzyme and calcium channel blocker intervene in the progression of renal disease besides by lowering systemic hypertension?]. Nagase M Nihon Rinsho; 1997 Aug; 55(8):2116-22. PubMed ID: 9284433 [TBL] [Abstract][Full Text] [Related]
14. Role of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in the prevention of progression of renal disease. Ram CV; Vergne-Marini P Curr Hypertens Rep; 1999 Oct; 1(5):431-5. PubMed ID: 10981102 [TBL] [Abstract][Full Text] [Related]
15. Update on calcium antagonists and the kidney. Tobe S Curr Opin Nephrol Hypertens; 2003 May; 12(3):309-15. PubMed ID: 12698071 [TBL] [Abstract][Full Text] [Related]
16. Renal protection and antihypertensive drugs: current status. Salvetti A; Mattei P; Sudano I Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294 [TBL] [Abstract][Full Text] [Related]
17. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy]. Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518 [TBL] [Abstract][Full Text] [Related]
18. Hypertension and progression of renal disease. Maschio G; Oldrizzi L; Marcantoni C; Rugiu C J Nephrol; 2000; 13(3):225-7. PubMed ID: 10928300 [TBL] [Abstract][Full Text] [Related]
19. Are antihypertensive drugs similar in protecting the kidney? Ritz E Am J Hypertens; 1995 Oct; 8(10 Pt 2):53S-58S. PubMed ID: 8845084 [TBL] [Abstract][Full Text] [Related]
20. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats. Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]